Antidepressant-like effects of a cocoa polyphenolic extract in Wistar-Unilever rats

Nutritional Neuroscience

Volumn 11, Issue 6, 2008, Pages 269-276

  Messaoudi, Michaël ^a,c   Bisson, Jean François ^a   Nejdi, Amine ^a   Rozan, Pascale ^a   Javelot, Hervé ^a,b  

^a ETAP Applied Ethology   (France)

^b Hôpital Psychiatrique   (France)

^c ETAP Research Centre   (France)

Author keywords

Cocoa polyphenolic extract; Depression; Flavonoids; Forced swimming test; Polyphenols; Rat

Indexed keywords

COCOA POLYPHENOLIC EXTRACT; IMIPRAMINE; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIDEPRESSANT LIKE EFFECT; ARTICLE; CACAO; CONTROLLED STUDY; DEPRESSION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SCREENING; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MORNING DOSAGE; MOTOR DYSFUNCTION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RAT STRAIN; WEIGHT GAIN;

ANIMALS; ANTIDEPRESSIVE AGENTS; BODY WEIGHT; CACAO; FLAVONOIDS; IMIPRAMINE; IMMOBILITY RESPONSE, TONIC; MALE; MOTOR ACTIVITY; PHENOLS; PLANT EXTRACTS; RATS; SEEDS; SWIMMING;

RATTUS; THEOBROMA CACAO;

EID: 56349122509     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683008X344165     Document Type: Article

References (78)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
2. Anisman H, Zacharko RM. Depression: the predisposing influence of stress. Behav Brain Sci 1982; 5: 89-137.
3. Anisman H, Zacharko RM. Depression as a consequence of inadequate neurochemical adaptation in response to stressors. Br J Psychiatry Suppl 1992; 15: 36-43.
4. Fava M, Kendler KS. Major depressive disorder. Neuron 2000; 28: 335-341.
5. Chambers CD, Hernandez-Diaz S, Van Matter LJ et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354: 579-587.
6. Lucena MI, Carvajal A, Andrade RJ, Velasco A. Antidepressant-induced hepatotoxicity. Expert Opin Drug Saf 2003; 2: 249-262.
7. Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002; 69: 119-140.
8. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-1011.
9. Hertog MG, Kromhout D, Aravanis C et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries studies. Arch Intern Med 1995; 155: 381-386.
10. Steinmetz KA, Potter JD. Vegetables, fruit and cancer prevention. J Am Diet Assoc 1996; 96: 1027-1039.
11. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996; 156: 637-642.
12. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidant and beyond. Am J Clin Nutr 2005; 81: 215S-217S.
13. do Rego JC, Benkiki N, Chosson E, Kabouche Z, Seguin E, Costentin J. Antidepressant-like effect of hyperfoliatin, a polyisoprenylated phloroglucinol derivative from Hypericum perfoliatton (Clusiaceae) is associated with an inhibition of neuronal monoamines uptake. Eur J Pharmacol 2007; 569: 197-203.
14. Whiskey E, Werneke U, Taylor D. A systematic review and metaanalysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol 2001; 16: 239-252.
15. Kalkunte SS, Singh AP, Chaves FC et al. Antidepressant and antistress activity of GC-MS characterized lipophilic extracts of Ginkgo biloba leaves. Phytother Res 2007; 21: 1061-1065.
16. Sakakibara. H, Ishida K, Grundmann O et al. Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models. Biol Pharm Bull 2006; 29: 1767-1770.
17. Mora S, Diaz-Véliz G, Millan R et al. Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from Aloysia polystachya in rats. Pharmacol Biochem Behav 2005: 82: 373-378.
18. Mora S. Millan R. Lungenstrass H et al. The hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like elfects in rats. J. Ethnopharmacol 2006: 106: 76-81.
19. Butterweck V, Nishibe S, Sasaki T. Uchida M. Antidepressant effects of Apocynum venetum leaves in a forced swimming test. Biol Pharm Bull 2001; 24: 848-851.
20. Butterweek V, Jürgenliemk G, Nahrstedt A, Winterhoff. H. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med 2000; 66: 3-6.
21. Butterweck V. Korte B, Winterhoff H. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Pharmacopsychiatry 2001; 34: S2-S7.
22. Rocha FF, Lima-Landman MT, Souccar C, Tanae MM, De Lima TC, Lapa AJ. Antidepressant-like effect of Cecropid glazioui Sneth and its constituents - in vivo and in vitro characterization of the underlying mechanism. Phytomedicine 2007; 14: 396-402.
23. Baba S, Osakabe N, Kato Y et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr 2007; 85: 709-717.
24. Manach C, Scalbert A, Morand C, Remezy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79:727-747.
25. Tapiero H, Tew KD, Ba GN, Mathe G. Polyphenols: do they play a role in the prevention of human pathologies? Biomed Pharmacother 2002; 56: 200-207.
26. Adamson GE, Lazarus SA, Mitchell AE et al. HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J Agric Food Chem 1999; 47: 4184-4188.
27. Hammerstone JF, Lazarus SA, Mitchell AE, Rucker R, Schmitz HH. Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem 1999; 47: 490-496.
28. Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin content and variation in some commonly consumed foods. J Nutr 2000; 130: 2086S-2092S.
29. Arteel GE, Sies H. Protection against peroxynitrite in cocoa polyphenols oligomers. FEBS Lett 1999; 462: 167-170.
30. Rozan P, Hidalgo S, Nejdi A, Bisson JF, Lalonde R, Messaoudi M. Preventive antioxidant effects of cocoa polyphenolic extract on free radical production and cognitive performances after heat exposure in Wistar rats. J Food Sci 2007; 72: S203-S206.
31. Bisson JF, Hidalgo S, Rozan P, Messaoudi M. Preventive effects of Acticoa powder, a cocoa polyphenolic extract, on experimentally induced prostate hyperplasia in Wistar-Unilever rats. J Med Food 2007; 10: 622-627.
32. Bisson JF, Hidalgo S, Rozan P, Messaoudi M. Therapeuitc Effect of Acticoa powder, a cocoa polyphenolic extract, on experimentally induced prostate hyperplasia in Wistar-Unilever rats. J Med Food 2007; 10: 628-635.
33. Bisson JF, Nejdi A, Hidalgo S, Rozan P, Lalonde R, Messaoudi M. Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats. Br J Nutr 2008; 100: 94-101.
34. Porsolt RD, Epichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266: 730-732.
35. Ramljak D, Romanczyk LJ, Metheny-Barlow LJ et al. Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther 2005; 4: 537-546.
36. Bisson JF, Guardia-Llorens MA, Hidalgo S, Rozan P, Messaoudi M. Protective effect of Acticoa powder, a cocoa polyphenolic extract, on prostate carcinogenesis in Wistar-Unilever rats. Eur J Cancer Prev 2008; 17: 54-61.
37. Matsui N, Ito R, Nishimura E, Yoshikawa M. Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism. Nutrition 2005; 21: 594-601.
38. Wang JF, Schramm DD, Holt RR et al. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 2000; 130: 2115S-2119S.
39. Zhu QY, Holt RR, Lazarus SA, Orozco TJ, Keen CL. Inhibitory effects of cocoa flavanols and procyanidin oligomers on free radical-induced erythrocyte hemolysis. Exp Biol Med 2002; 227: 321-329.
40. Taubert D, Roesen R, Lehmann C, Jung N, Schomig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide. JAMA 2007: 298: 49-60.
41. Keen CL, Holt RR, Polaguto JA, Wang JE. Schmitz HH. Cocoa flavanols and cardiovascular health. Phytochem Rev 2002; 1: 231-240.
42. Engler MB, Engler MM. The vasculoprotective effects of flavonoid-rich cocoa and chocolate. Nutr Res 2004; 24: 695-706.
43. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA 2003; 290: 1030-1031.
44. Farouque HMO. Leung M, Hope SA et al. Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci 2006: 111:71-80.
45. Allen RR, Carson LA, Kwik-Uribe C, Evans EM, Erdman JW. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J Nutr 2008; 138: 725-731.
46. Ruzaidi AMM, Amin I, Nawalyah AG, Hamid M, Faizul HA. The effect of Malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats. J Ethnopharmacol 2005; 98: 55-60.
47. Ruzaidi AMM, Abbe MMJ, Amin I, Nawalyah AG, Muhajir H. Protective effect of polyphenol-rich extract prepared from Malaysian cocoa (Theobroma cacao) on glucose levels and lipid profiles in streptozotocin-induced diabetic rats. J Sci Food Agric 2008; 88: 1442-1447.
48. Tomaru M, Takano H, Osakabe N et al. Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice. Nutrition 2007; 23: 351-355.
49. Dietrich-Muszalska A. Olas B. Rabe-Jablonska J. Oxidative stress in blood platelets from schizophrenic patients. Platelets 2005; 16: 386-391.
50. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Oxford Science Publications, 2000.
51. Herken H, Gurel A, Selek S et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007; 38: 247-252.
52. Michel TM, Frangou S, Thiemeyer D et al. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder - a postmortem study. Psychiatry Res 2007; 151: 145-150.
53. Ozcan ME, Gulec M, Ozerof E, Polat R, Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004; 19: 89-95.
54. Savas HA, Herken H, Yürekli M et al. Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 2002; 45: 57-61.
55. Savas HA, Gergerlioglu HS, Armutcu F et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 2006; 7: 51-55.
56. Yanik M, Vural H, Kocyigit A et al. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 2003; 47: 61-65.
57. Zhou F, Zhang W, Wei Y et al. The changes of oxidative stress and human 8-hydroxyguanine glycosylase 1 gene expression in depressive patients with acute leukemia. Leukoc Res 2007; 31: 387-393.
58. Porsolt RD, Anton G, Daniel M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 17: 379-391.
59. Porsolt RD. Behavioral despair. In: Enna SJ. (ed) Antidepressants: neurochemical, behavioral and clinical perspectives. New York: Raven Press, 1981; 121-139.
60. Cryan JF, Page ME, Lucki I. Differential behavioural effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology 2005; 182:335-344.
61. Okiyama M, Ueno K, Ohkawara S, Ohmori S, Igarashi T, Kitagawa H. Effects of combined administration of diazepam and imipramine hydrochloride in rats. J Pharm Sci 1986; 75: 1071-1075.
62. Vanina Y, Podolskaya A, Sedky K et al. Body weight changes associated with psychopharmacology. Psychiatr, Serv 2002; 53: 842-847.
63. Pan Y. Kong L. Xia X. Zhang W. Xia Z. Jiang F. Antidepressant-like effect of icanin and its possible mechanism in ice. Pharmacol Biochem Behav 2005: 82: 686-694.
64. Holt RR, Lazarus SA, Sullards MC et al. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr 2002; 76: 798-804.
65. Rein D, Paglieroni TG, Wun T et al. Cocoa inhibits platelet activation and function. Am J Clin Nutr 2000; 72: 30-35.
66. Strandberg TE. Strandberg AY. Pitkälä K. Salomaa VV. Tilvis RS. Miettinen TA. Chocolate, well-being and health among elderly men. Eur J Clin Nutr 2007; 62: 247-253.
67. Pan TH, Jankovic J, Le WD. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 2003; 20: 711-721.
68. Schroeter H, Williams RJ, Matin R, Iversen L, Rice-Evans CA. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic Biol Med 2000; 29: 1222-1233.
69. Kim HK, Kim M, Kim S, Kim M, Chung JH. Effects of green tea polyphenol on cognitive and acetylcholinesterase activities. Biosci Biotechnol Biochem 2004; 68: 1977-1979.
70. Mandel S, Weinreb, Amit T, Youdim MBH. Cell signalling pathways in the neuroprotective actions of the green tea polyphenols (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J Neurochem 2004; 88: 1555-1569.
71. Lamuela-Raventos RM, Andres-Lacueva C, Permanyer J, Izquierdo-Pulido M. More antioxidants in cocoit. J Nutr 2001; 131: 834-835.
72. Sanbongi C, Osakabe N, Natsume M, Takizawa T, Gomi S, Osawa T. Antioxidative polyphenols isolated from Theobroma cacao. J Agric Food Chem 1998; 46: 454-457.
73. Anjaneyulu M, Chopra K, Kaur I. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food 2003; 6: 391-395.
74. Kaur R, Chopra K, Singh D. Role of alpha2 receptors in quercetin-induced behavioral despair in mice. J Med Food 2007; 10: 165-168.
75. Sakakibara H, Yoshino S, Kawai Y, Terao J. Antidepressant-like effect of onion (Allium cepa L.) powder in a rat behavioral model of depression. Biosci Biotechnol Biochem 2008; 72: 94-100.
76. Poleszak E, Szewczyk B, Kedzierska E, Wlaz P, Pilc A, Nowak G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav 2004; 78: 7-12.
77. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006; 67: 362-370.
78. Bilici M, Efe H, Köroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64: 43-51.